Wei Cheng Zhou

Jiangsu Deyuan Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of modern pharmaceutical products. The company also focuses on development, production and sale of therapeutic drugs in the fields of hyperglycemia, hyperlipaemia and hypertension. Its products include endocrine, cardiovascular and psychotropic drugs. The company was founded on October 29, 2004 and is headquartered in Lianyungang, China.

Jiangsu Deyuan Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of modern pharmaceutical products. The company also focuses on development, production and sale of therapeutic drugs in the fields of hyperglycemia, hyperlipaemia and hypertension. Its products include endocrine, cardiovascular and psychotropic drugs. The company was founded on October 29, 2004 and is headquartered in Lianyungang, China.

Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. Its product pipelines focus on the treatment of resistant Gram-positive and Gram-negative bacterial infections. The company was founded by Zheng Yu Yuan and Mikhail F. Gordeev on August 7, 2012 and is headquartered in Shanghai, China.

Jiangsu Deyuan Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of modern pharmaceutical products. The company also focuses on development, production and sale of therapeutic drugs in the fields of hyperglycemia, hyperlipaemia and hypertension. Its products include endocrine, cardiovascular and psychotropic drugs. The company was founded on October 29, 2004 and is headquartered in Lianyungang, China.

Jiangsu Deyuan Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of modern pharmaceutical products. The company also focuses on development, production and sale of therapeutic drugs in the fields of hyperglycemia, hyperlipaemia and hypertension. Its products include endocrine, cardiovascular and psychotropic drugs. The company was founded on October 29, 2004 and is headquartered in Lianyungang, China.

Jiangsu Deyuan Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of modern pharmaceutical products. The company also focuses on development, production and sale of therapeutic drugs in the fields of hyperglycemia, hyperlipaemia and hypertension. Its products include endocrine, cardiovascular and psychotropic drugs. The company was founded on October 29, 2004 and is headquartered in Lianyungang, China.

Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. Its product pipelines focus on the treatment of resistant Gram-positive and Gram-negative bacterial infections. The company was founded by Zheng Yu Yuan and Mikhail F. Gordeev on August 7, 2012 and is headquartered in Shanghai, China.

Jiangsu Deyuan Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of modern pharmaceutical products. The company also focuses on development, production and sale of therapeutic drugs in the fields of hyperglycemia, hyperlipaemia and hypertension. Its products include endocrine, cardiovascular and psychotropic drugs. The company was founded on October 29, 2004 and is headquartered in Lianyungang, China.

Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. Its product pipelines focus on the treatment of resistant Gram-positive and Gram-negative bacterial infections. The company was founded by Zheng Yu Yuan and Mikhail F. Gordeev on August 7, 2012 and is headquartered in Shanghai, China.

Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. Its product pipelines focus on the treatment of resistant Gram-positive and Gram-negative bacterial infections. The company was founded by Zheng Yu Yuan and Mikhail F. Gordeev on August 7, 2012 and is headquartered in Shanghai, China.

Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. Its product pipelines focus on the treatment of resistant Gram-positive and Gram-negative bacterial infections. The company was founded by Zheng Yu Yuan and Mikhail F. Gordeev on August 7, 2012 and is headquartered in Shanghai, China.

Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. Its product pipelines focus on the treatment of resistant Gram-positive and Gram-negative bacterial infections. The company was founded by Zheng Yu Yuan and Mikhail F. Gordeev on August 7, 2012 and is headquartered in Shanghai, China.

Jiangsu Deyuan Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of modern pharmaceutical products. The company also focuses on development, production and sale of therapeutic drugs in the fields of hyperglycemia, hyperlipaemia and hypertension. Its products include endocrine, cardiovascular and psychotropic drugs. The company was founded on October 29, 2004 and is headquartered in Lianyungang, China.

Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. Its product pipelines focus on the treatment of resistant Gram-positive and Gram-negative bacterial infections. The company was founded by Zheng Yu Yuan and Mikhail F. Gordeev on August 7, 2012 and is headquartered in Shanghai, China.

Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. Its product pipelines focus on the treatment of resistant Gram-positive and Gram-negative bacterial infections. The company was founded by Zheng Yu Yuan and Mikhail F. Gordeev on August 7, 2012 and is headquartered in Shanghai, China.

Jiangsu Deyuan Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of modern pharmaceutical products. The company also focuses on development, production and sale of therapeutic drugs in the fields of hyperglycemia, hyperlipaemia and hypertension. Its products include endocrine, cardiovascular and psychotropic drugs. The company was founded on October 29, 2004 and is headquartered in Lianyungang, China.

Jiangsu Deyuan Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of modern pharmaceutical products. The company also focuses on development, production and sale of therapeutic drugs in the fields of hyperglycemia, hyperlipaemia and hypertension. Its products include endocrine, cardiovascular and psychotropic drugs. The company was founded on October 29, 2004 and is headquartered in Lianyungang, China.

Jiangsu Deyuan Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of modern pharmaceutical products. The company also focuses on development, production and sale of therapeutic drugs in the fields of hyperglycemia, hyperlipaemia and hypertension. Its products include endocrine, cardiovascular and psychotropic drugs. The company was founded on October 29, 2004 and is headquartered in Lianyungang, China.

Jiangsu Deyuan Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of modern pharmaceutical products. The company also focuses on development, production and sale of therapeutic drugs in the fields of hyperglycemia, hyperlipaemia and hypertension. Its products include endocrine, cardiovascular and psychotropic drugs. The company was founded on October 29, 2004 and is headquartered in Lianyungang, China.

Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. Its product pipelines focus on the treatment of resistant Gram-positive and Gram-negative bacterial infections. The company was founded by Zheng Yu Yuan and Mikhail F. Gordeev on August 7, 2012 and is headquartered in Shanghai, China.